Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Genome Med
; 14(1): 58, 2022 05 30.
Article
in En
| MEDLINE
| ID: mdl-35637530
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pleural Neoplasms
/
Mesothelioma, Malignant
/
Lung Neoplasms
/
Mesothelioma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Genome Med
Year:
2022
Document type:
Article
Affiliation country:
Australia
Country of publication:
Reino Unido